PAR
Click for more information
1.96% 26.0¢ paradigm biopharmaceuticals limited..

PATENT REJECTED BUT PAR SILENT, page-13

  1. Leroy65
    318 Posts.
    lightbulb Created with Sketch. 37
    clock Created with Sketch.
    11/04/22
    06:57
    Post #: 60772550
    This is an interesting article on drug repurposing but your heading is misleading
    I can't see any mention of PAR at all but worth a read
    PAR Price at posting: $1.15 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ARU Arafura updates gas supply agreement with Mereenie JV for 16.4PJ supply to Nolans REE play
right-arrow Created with Sketch.
DEG De Grey sees more production at Hemi with latest drilling at Crow, Aquila
right-arrow Created with Sketch.
NEWS Training with professional athletes: How to invest like the best
right-arrow Created with Sketch.
IDA Indiana Resources to win US$90M from Tanzania following international lawsuit
right-arrow Created with Sketch.
MTL Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
right-arrow Created with Sketch.
NEWS Super PITch gold sponsor RSM Australia: Can Diggers & Dealers 2024 be key to reinvigorating IPO activity?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.0¢ 		Change
0.005(1.96%) 		Mkt cap ! $90.94M
Open High Low Value Volume
26.0¢ 27.0¢ 25.5¢ $120.3K 464.3K

Buyers (Bids)

No. Vol. Price($)
8 96377 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 55689 11
View Market Depth
Last trade - 13.27pm 30/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.